Form 8-K - Current report:
SEC Accession No. 0001742924-23-000014
Filing Date
2023-05-02
Accepted
2023-05-02 16:26:17
Documents
14
Period of Report
2023-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lthm-20230502.htm   iXBRL 8-K 34698
2 EX-99.1 liventex9913312023.htm EX-99.1 230294
6 liventhrgb1002a12a.jpg GRAPHIC 58137
  Complete submission text file 0001742924-23-000014.txt   499250

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lthm-20230502.xsd EX-101.SCH 1908
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lthm-20230502_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lthm-20230502_pre.xml EX-101.PRE 12512
8 EXTRACTED XBRL INSTANCE DOCUMENT lthm-20230502_htm.xml XML 11339
Mailing Address 1818 MARKET STREET PHILADELPHIA PA 19103
Business Address 1818 MARKET STREET PHILADELPHIA PA 19103 215-299-5900
Livent Corp. (Filer) CIK: 0001742924 (see all company filings)

EIN.: 824688610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38694 | Film No.: 23879479
SIC: 2800 Chemicals & Allied Products